Genes in the spondyloarthropathies

Area of Science:

• Immunogenetics
• Rheumatology
• Human Genetics

Background:

• Ankylosing spondylitis (AS) is a complex genetic autoimmune disease.
• The human leukocyte antigen B27 (HLA-B27) is strongly associated with AS, but accounts for less than 50% of the genetic contribution.
• Other human leukocyte antigen (HLA) class I and class II molecules may also influence AS susceptibility.

Purpose of the Study:

• To explore the genetic architecture of ankylosing spondylitis beyond the well-established HLA-B27 association.
• To identify novel genetic loci contributing to AS pathogenesis.
• To lay the groundwork for understanding AS etiology and developing targeted therapies.

Main Methods:

• Analysis of genetic contributions to ankylosing spondylitis (AS).
• Investigation of human leukocyte antigen (HLA) class I and class II associations.
• Whole genome screening in affected sibling pairs to identify potential genetic regions.

Main Results:

• The human leukocyte antigen (HLA) region, including HLA-B27 and HLA-B60, plays a significant role but explains less than half of the genetic variance in AS.
• Whole genome screening identified several regions of interest for further investigation in affected sibling pairs.
• HLA class II associations suggest potential independent effects or linkage disequilibrium with other relevant genetic loci.

Conclusions:

• The genetic etiology of ankylosing spondylitis (AS) is complex and involves multiple genetic loci beyond HLA-B27.
• Future research will focus on confirming and refining identified genetic linkages and evaluating candidate genes.
• A comprehensive understanding of AS genetics is crucial for elucidating pathogenic mechanisms and advancing treatment and prevention strategies.